Using Artificial Intelligence to Get the Right Drug to the Right Patient at the Right Time

OM1's Stefan Weiss, M.D., FAAD, discusses the promise of real-world data and how OM1 is leveraging AI to overcome the inherent challenges associated with analyzing data in non-structured electronic medical records at scale.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: